We investigated the type of receptors involved in the mechanism of action of dopamine on corticosteroid secretion from the frog interrenal (adrenal) 
Taken together, these data indicate that dopamine directly regulates corticosteroid secretion from frog adrenocortical cells. The effect of dopamine is not coupled to adenylate cyclase activity but is probably mediated through the phosphoinositide-turnover pathway. The pharmacological characteristics of the receptors involved in the mechanism of action of dopamine clearly differ from those of the D1 and D2 subtypes previously described in mammals. INTRODUCTION Several lines of evidence suggest that dopamine exerts inhibitory control on aldosterone secretion in man and other mammalian species (for reviews see Cuche, 1988; Fraser, Connell, Inglis et al. 1989 ). Based on pharmacological, biochemical and physio¬ logical criteria, dopamine receptors are classically divided into two subtypes, V>\ and D2 (for reviews see Niznik, 1987; Seeman 6k Grigoriadis, 1987; Vallar 6k Meldolesi, 1989; Andersen, Gingrich, Bates et al. 1990 ). In peripheral tissues, including the adrenal cortex, activation of the D¡ receptor subtype is generally associated with an increase of adenylate cyclase activity, while the D2 receptor subtype is considered to be negatively coupled to adenylate cyclase (Missale, Memo 6k Spano, 1985;  1987; Login, Judd 6k MacLeod, 1988) and/or acti¬ vation of potassium channels (Israel, Jaquet 6k Vincent, 1985; Israel, Kirk 6k Vincent, 1987) .
It is now well accepted that dopamine-evoked inhibition of aldosterone secretion from glomerulosa cells is mediated through activation of D2 receptors (for review see Fraser et al. 1989 ). However, the mechanism of action of dopamine in the adrenal cortex has not been extensively studied. We have previously shown that dopamine evokes a direct dose-dependent inhibition of corticosteroid pro¬ duction from the perifused frog interrenal gland (Morra, Leboulenger 6k Vaudry, 1990 (Missale et al. 1985 (Missale et al. , 1986 , and a recent study indicates that, in rat zona glomerulosa cells, dopa¬ mine stimulates both cyclic AMP (cAMP) pro-. duction and aldosterone secretion through activation of a XJi receptor subtype (Gallo-Payet, Chouinard, Balestreck .
The aim of the present study was to characterize the kinetics of the response of frog adrenocortical cells to dopamine, and to determine the pharmaco¬ logical and biochemical profiles of the dopamine receptors involved in the regulation of corticosteroid production.
MATERIALS AND METHODS

Animals
Adult male frogs (Rana ridibunda), of [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] N,N-diethyl-N'-[(3a,4aa,10ß)-l,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1 -propyl-3 -benzo [9] quinolinyl] sulphamide (CV205-502) was from Sandoz Ltd (Basel, Switzer¬ land). 4, 4a, 5, 6, 7, 8, 8a, (Fig. 1) . The kinetics of the responses were very similar for both corticosterone and aldosterone.
The lag period between the onset of dopamine infusion and the beginning of the response was 10 min, the maximum amplitude of the stimulatory phase occurred 30 min after the onset of dopamine infusion and the maximum inhibition was observed after 60-70 min. Repeated administration of equimolar doses of dopamine at 150-min intervals resulted in a twofold increase in the amplitude of the stimulatory phase after the second infusion, and in a dramatic reduction after the third infusion (Fig. 1) (Fig. 4a and b) (Missale et al. 1985 (Missale et al. , 1986 Seeman 6k Grigoriadis, 1987) .
The specificity of action of SKF38393 and dopa¬ mine, and thus the presence of authentic Di recep- [3H]Myo-inositol-prelabelled interrenal slices were exposed for 10min to dopamine (50 um (Missale et al. 1985 (Missale et al. , 1986 . In contrast, in bovine zona glomerulosa cells, high concentrations of dopamine (up to 100 pM) are devoid of effect on basal cAMP forma¬ tion (Bevilacqua, Vago, Scorza 6k Norbiato, 1982; Stern, Tuck, Ozaki 6k Krall, 1986 (Sunahara, Guan, O'Dowd et al. 1991) . These data clearly demonstrate that a variety of dopamine receptors exhibiting distinct pharmacological and biochemical profiles are expressed in a tissuespecific manner.
In conclusion, our results indicate that the com¬ plex effects of dopamine on corticosteroid secretion can be accounted for by recruitment of two receptor subtypes which are coupled to phospholipase C activity and independent from the adenylate cyclase system. These receptors are different from the classical T)\ and D2 subtypes previously described in mammals. Molecular characterization of these re¬ ceptors should provide crucial information concern¬ ing diversification of dopamine receptor subtypes during evolution.
